In this episode of Hart2Heart, host Dr. Mike Hart talks with Dr. Boris Heifetz, an assistant professor of anesthesiology at Stanford. Dr. Heifetz shares insights from his extensive research and clinical experience, touching on topics like the placebo effect, the interplay between drugs and patient psychology, and the future of psychedelic medicine.
Show Notes:
[0:00] Welcome back to the Hart2Heart Podcast with Dr. Mike Hart. Dr. Hart introduces the guest, Dr. Boris Heifetz to the listeners
[0:30] Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
[4:15] The debate of drug vs. ‘trip’ in psychedelic therapy
[7:45] “The short answer is, I think you can achieve psychological transformation without dissociation.”
[10:00] Ketamine for suicidal ideations
[18:00] The concept of dream awakening and its impact on trauma
[20:00] Discussing the scalability and accessibility of psychedelic therapy
[22:00] Importance of aftercare in psychedelic treatments
[30:00] Ketamine and opioid-like effects discussed
[31:45] Painkiller
[37:00] Dr. Boris Heifetz reiterates the idea of an inner healing intelligence
[42:00] The interplay between SSRIs and psychedelics
[52:00] Question: Do you feel ketamine falls into the care of family physicians? Or do you feel like that should be delegated more to anesthetists and psychiatrists?
[53:30] If you want to know more about Dr. Boris Heifetz check him out on X @TheBorisLab or at https://heifetslab.stanford.edu/
---
Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap which exists in the medical community.
Connect on social with Dr. Mike Hart:
Social Links:
Instagram: @drmikehart
Twitter: @drmikehart
Facebook: @drmikehart
